Amgen to invest $200 million in India site, CEO saysAmgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre,...
24 Feb, 2025, 01.21 PM IST
Amgen expands global capability centre in Hyderabad with 500,000 sq ft leaseAmgen leases 500,000 sq ft in Hyderabad to establish its first global capability centre, enhancing its office space in the city. The new ce...
05 Feb, 2025, 03.01 PM IST
Telangana CM secures over Rs 31,500 cr plans in US tour, leaves for South KoreaThe delegation held Roundtable Conferences on business, AI and semiconductors, spanning coast to coast, and also met with CEOs, founders an...
12 Aug, 2024, 08.01 AM IST
Biotech giant Amgen plans to open to technology & innovation centre in HyderabadUS biotech giant Amgen announced plans to open a new technology and innovation site in Hyderabad, India. The site will be located in HITEC ...
09 Aug, 2024, 04.00 PM IST
The margin of safety: the ten-billion-dollar lesson from AmgenA notable book that emphasized the importance of corporate culture by looking at successful companies (stock price performance as a guide) ...
21 Feb, 2024, 12.47 PM IST
Cadila Pharma appoints Ashraf Allam global COOAllam, who served as the CEO at the Public Investment Fund prior to joining Cadila Pharmaceuticals, will report to Group Chairman and Manag...
19 Dec, 2022, 10.48 PM IST
Syngene can put on muscle as global pharma companies increase R&D spendingSyngene is a fully integrated CRAMS company and Biocon has around 70% stake in it. Syngene also has a wholly-owned subsidiary in the US.
27 Apr, 2022, 07.07 PM IST
Syngene's CEO Jonathan Hunt says India now offers intellectual arbitrage to firms“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...
31 Jul, 2021, 11.37 AM IST
Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare SummitNITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...
19 Jun, 2021, 10.15 AM IST
Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...
31 Aug, 2020, 08.49 AM IST
Twelve stocks in focus on Wednesday, 07 September 2016The Indian market is expected to open higher. Here is a list of top twelve stocks that are likely to be in focus today.
07 Sep, 2016, 08.02 AM IST
How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.
29 Sep, 2015, 02.51 AM IST
Why Indian entrepreneurs are missing at the top in both biotech and consumer tech cos in Silicon ValleyTechnology becomes more and more important as consumer technology companies grow. Facebook and Twitter now use analytics intensely.
18 Aug, 2015, 09.44 AM IST
- Cipla to partner Chinese co in selling Roche, Amgen drug clones
Cipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...
17 Jun, 2010, 02.44 AM IST
- Parag Saxena to raise $1.5 bn for Asia fund with India focus
Parag Saxena, one of the leading venture capitalists in the US and an early investor in Starbucks, is raising $1.5 billion for a dedicated ...
25 Sep, 2007, 03.23 AM IST
- Dr Reddy's developing 8 more biotech drugs
Dr. Reddy's Laboratories developing eight generic medicines using biotechnology.
21 Jun, 2007, 12.25 PM IST
- Global pharma cos explore contract research in India
A new chapter is being added to the Indian pharma story. Leading global pharma and biotechnology firms, such as Schering-Plough, Bristol-My...
21 Oct, 2006, 03.05 AM IST